Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Antonini RA et al. | 2006 | intact cell/cell culture, SH-SY5Y (human neuroblastoma cell line) | low frequency, 50/60 Hz, power transmission line, magnetic field | 1–2 mT |
Reale M et al. | 2006 | intact cell/cell culture, human monocytes | magnetic field, 50/60 Hz, co-exposure | 1 mT |
Savage Jr RE et al. | 2005 | intact cell/cell culture, SF767 (human glioma cell line) | magnetic field, low frequency, 50/60 Hz | 1.2 µT |
Ventura C et al. | 2005 | intact cell/cell culture, GTR1 cells (derivative of R1 embryonic stem cells) | magnetic field, 50/60 Hz | 0.8 mT |
Volpe P et al. | 2005 | intact cell/cell culture, FL cells (Friend erythroleukemia cells) | magnetic field, geomagnetic field, 50/60 Hz, shielding/field deprivation | 0.0025 nT–70 µT |
Li H et al. | 2005 | intact cell/cell culture, MCF-7 (human breast cancer cell line) | magnetic field, 50/60 Hz | 0.4 mT |
Luceri C et al. | 2005 | intact cell/cell culture, yeast (<i>Saccharomyces cerevisiae</i>/strain DBY747) | magnetic field, low frequency, 50/60 Hz | 0.1–100 µT |
Bodega G et al. | 2005 | intact cell/cell culture, astroglial cells of P0-P1 Wistar rats | magnetic field, static magnetic field, 50/60 Hz | 1 mT |
Malagoli D et al. | 2004 | invertebrate, mussel/<i>Mytilus galloprovincialis</i>, whole body | magnetic field, 50/60 Hz | 300–600 µT |
Somosy Z et al. | 2004 | intact cell/cell culture, Madin-Darby canine kidney (MDCK) cells | magnetic field, 50/60 Hz | 500 µT |
Olivares-Banuelos T et al. | 2004 | intact cell/cell culture, chromaffin cells (from neonatal Wistar rats) | magnetic field, 50/60 Hz | 700 µT |
Grassi C et al. | 2004 | intact cell/cell culture, human neuroblastoma cell line (IMR 32) and rat pituitary (GH3) cell line | magnetic field, low frequency, 50/60 Hz, co-exposure | 200–500 µT |
Czyz J et al. | 2004 | intact cell/cell culture, D3 (murine embryonic stem cell line, p53-deficient and wild type) | magnetic field, 50/60 Hz, power transmission line | 100 µT–2.3 mT |
Nie K et al. | 2003 | intact cell/cell culture, HL-60 cells (human acute myeloid leukaemia cell line), MCF-7 cells (breast cancer cell line), 3Y1 cells (rat fibroblast cells) | magnetic field, 50/60 Hz, shielding/field deprivation | 100 µT |
Shi B et al. | 2003 | intact cell/cell culture, human fibroblasts (derived from neonatal foreskin) | magnetic field, 50/60 Hz | 8.4 mT |
Nakasono S et al. | 2003 | intact cell/cell culture, yeast (<i>Saccharomyces cerevisiae</i>) | magnetic field, 50/60 Hz | 10 mT |
Santini MT et al. | 2003 | intact cell/cell culture, human osteosarcoma cell lines (MG-63 and Saos-2) | magnetic field, 50/60 Hz | 500 µT |
Tuncel H et al. | 2002 | animal, rat/Wistar albino, whole body | magnetic field, 50/60 Hz | 5 mT |
Ding GR et al. | 2002 | intact cell/cell culture, MO54 cells (derived from a human malignant glioma) | magnetic field, 50/60 Hz, co-exposure | 5 mT |
Zhou J et al. | 2002 | intact cell/cell culture, HL-60 (human acute myeloid leukaemia cells) | magnetic field, 50/60 Hz | 0.1–0.8 mT |
Rao RR et al. | 2002 | intact cell/cell culture, IMR 32 (human neuroblastoma cells) | magnetic field, 50/60 Hz | 50–200 µT |
Richard D et al. | 2002 | intact cell/cell culture, human diploid amniotic fluid cells | magnetic field, 50/60 Hz, co-exposure | 1 mT |
Yomori H et al. | 2002 | intact cell/cell culture, T98G (human glioblastoma) cells | magnetic field, 50/60 Hz | 1–500 µT |
Still M et al. | 2002 | intact cell/cell culture, Jurkat cells (clone E6-1; T-lymphocyte hybridoma cell line) | magnetic field, 50/60 Hz, DC, static magnetic field | 10–100 µT |
Ding GR et al. | 2001 | intact cell/cell culture, MCF-7 (human breast cancer cell line) | magnetic field, 50/60 Hz, co-exposure | 5 mT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.